Safe-harbour follow up

With no further delay, the highcourt ruled, http://econ.st/1VAkgSF

Updated October 6th 2015: EUROPE'S highest court today struck down the safe-harbour agreement, arguing that "legislation permitting [American] public authorities to have access on a generalised basis to the content of electronic communications must be regarded as compromising the essence of the fundamental right to respect for private life." The judges also ruled that national data-protection authorities within the EU do have the right independently to examine firms which transfer personal data across the Atlantic. In its initial statement the court did not mention a grace period that would allow companies to adapt to the ruling

Generally, ensuring data received by US to be anonymized would be ideal and a common practice available to industries but might be more challenging for Pharmas based on US FDA requirements – meaning clinical monitoring and subject follow-up / additions would not be feasible = trade-off. "clear guidance" said to follow